Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Prepared by the Office of Parliamentary Counsel, Canberra
National Health (Originator Brand)
Determination 2015 (PB 100 of 2015)
made under subsection 99ADB(6B) of the
National Health Act 1953
Compilation No. 40
Compilation date: 1 October 2020
Includes amendments up to: PB 96 of 2020
Registered: 8 October 2020
Authorised Version F2020C00906 registered 08/10/2020
About this compilation
This compilation
This is a compilation of the National Health (Originator Brand) Determination 2015 (PB 100
of 2015) that shows the text of the law as amended and in force on 1 October 2020 (the
compilation date).
The notes at the end of this compilation (the endnotes) include information about amending
laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any
uncommenced amendments affecting the law are accessible on the Legislation Register
(www.legislation.gov.au). The details of amendments made up to, but not commenced at, the
compilation date are underlined in the endnotes. For more information on any uncommenced
amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an
application, saving or transitional provision that is not included in this compilation, details are
included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the
modification does not amend the text of the law. Accordingly, this compilation does not show
the text of the compiled law as modified. For more information on any modifications, see the
series page on the Legislation Register for the compiled law.
Self-repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the
law, details are included in the endnotes.
Authorised Version F2020C00906 registered 08/10/2020
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) i
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Contents 1 Name of Determination ............................................................................................... 1 3 Definition .................................................................................................................... 1 4 Originator Brand ......................................................................................................... 1
Schedule 1—Originator Brand 2
Endnotes 32
Endnote 1—About the endnotes 32
Endnote 2—Abbreviation key 33
Endnote 3—Legislation history 34
Endnote 4—Amendment history 36
Authorised Version F2020C00906 registered 08/10/2020
Section 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 1
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
1 Name of Determination
(1) This Determination is the National Health (Originator Brand)
Determination 2015.
(2) This Determination may also be cited as PB 100 of 2015.
3 Definition
In this Determination:
Act means the National Health Act 1953.
4 Originator Brand
(1) For subsection 99ADB(6B) of the Act, unless subsections (2) or (3) of this
section apply, an originator brand specified in column 3 of an item in Schedule 1
is an originator brand for all brands of pharmaceutical item containing the drug
specified in column 2 of the same item in Schedule 1.
(2) Where a manner of administration is specified in column 4 of an item in
Schedule 1, an originator brand specified in column 3 of that item in Schedule 1
is an originator brand for all brands of pharmaceutical item containing the drug
specified in column 1, with the manner of administration specified in column 4
of the same item in Schedule 1.
(3) Where a form is specified in column 5 of an item in Schedule 1, an originator
brand specified in column 3 of that item in Schedule 1 is an originator brand for
all brands of pharmaceutical item containing the drug specified in column 2, with
the manner of administration specified in column 4 in the form specified in
column 5 of the same item in Schedule 1.
Note: A brand of an exempt item is not an originator brand due to section 99ADA of the Act.
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
2 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Schedule 1—Originator Brand (section 4)
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
1 Abacavir with Lamivudine Kivexa
1A Abatacept Orencia
Orencia Clickject
1B Acamprosate Campral
1C Acarbose Glucobay 50
Glucobay 100
1D Aciclovir Zovirax
Zovirax 200 mg
Zovirax 800 mg
2 Acitretin Neotigason
3 Adefovir Hepsera
3A Adrenaline (epinephrine) EpiPen
EpiPen Jr.
4 Alendronic acid with colecalciferol Fosamax Plus
Fosamax Plus 70 mg/140 mcg
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 3
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
5 Alendronic acid with colecalciferol
and calcium
Fosamax Plus D-Cal
6 Allopurinol Zyloprim
7 Aluminium Hydroxide with
Magnesium Hydroxide
Mylanta P
8 Amiodarone Cordarone X 100
Cordarone X 200
9 Amisulpride Solian 100
Solian 200
Solian 400
10 Amlodipine Norvasc
11 Amlodipine with Atorvastatin Caduet 5/10
Caduet 5/20
Caduet 5/40
Caduet 5/80
Caduet 10/10
Caduet 10/20
Caduet 10/40
Caduet 10/80
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
4 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
12 Amlodipine with valsartan Exforge 5/80
Exforge 5/160
Exforge 5/320
Exforge 10/160
Exforge 10/320
13 Amlodipine with valsartan and
hydrochlorothiazide
Exforge HCT 5/160/12.5
Exforge HCT 5/160/25
Exforge HCT 10/160/12.5
Exforge HCT 10/160/25
Exforge HCT 10/320/25
14 Amoxicillin Amoxil
Amoxil Forte
15 Amoxicillin with clavulanic acid Augmentin
Augmentin Duo
Augmentin Duo 400
Augmentin Duo forte
16 Anastrozole Arimidex
16A Apomorphine Apomine
Apomine Intermittent
Apomine Solution for Infusion
16B Aripiprazole Abilify Oral
Abilify Maintena Injection
16C Atazanavir Reyataz
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 5
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
17 Atenolol Tenormin
17A Atomoxetine Strattera
18 Atorvastatin Lipitor
18A Azacitidine Vidaza
19 Azathioprine Imuran
20 Azithromycin Zithromax
21 Baclofen Lioresal Intrathecal
Lioresal 10
Lioresal 25
22 Betamethasone Diprosone Application
Celestone Chronodose Injection
23 Betaxolol Betoptic
Betoptic S
24 Bicalutamide Cosudex
24A Bimatoprost Lumigan
Lumigan PF
25 Bisoprolol Bicor
25A Bivalirudin Angiomax
25B Bosentan Tracleer
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
6 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
26 Brimonidine Alphagan
Alphagan P 1.5
27 Brinzolamide Azopt
28 Bromocriptine Parlodel
28A Budesonide with formoterol Symbicort Rapihaler 50/3
Symbicort Rapihaler 100/3
Symbicort Rapihaler 200/6
Symbicort Turbuhaler 100/6
Symbicort Turbuhaler 200/6
Symbicort Turbuhaler 400/12
28B Buprenorphine Buvidal Monthly
Buvidal Weekly
Injection
Subutex Sublingual
Norspan Transdermal
29 Bupropion Zyban
30 Cabergoline Cabaser
Dostinex
30A Calcipotriol with betamethasone Daivobet
Daivobet 50/500 gel
31 Calcitriol Rocaltrol
32 Candesartan Atacand
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 7
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
33 Candesartan with
Hydrochlorothiazide
Atacand Plus 16/12.5
Atacand Plus 32/12.5
Atacand Plus 32/25
34 Capecitabine Xeloda
35 Captopril Capoten
36 Carbamazepine Tegretol 100
Tegretol 200
Tegretol CR 200
Tegretol CR 400
37 Carbomer Viscotears
Viscotears Gel PF
38 Carvedilol Dilatrend 3.125
Dilatrend 6.25
Dilatrend 12.5
Dilatrend 25
39 Cefaclor Ceclor
Ceclor CD
39A Cefalexin Keflex
39B Cefuroxime Zinnat
40 Celecoxib Celebrex
41 Certolizumab pegol Cimzia
41A Chorionic gonadotrophin Pregnyl
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
8 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
41B Ciclosporin Neoral 25
Neoral 50
Neoral 100
42 Ciprofloxacin Ciproxin 250
Ciproxin 500
Oral
Ciloxan Application to the eye
43 Citalopram Cipramil
44 Clarithromycin Klacid
45 Clindamycin Dalacin C
46 Clomifene Clomid
47 Clomipramine Anafranil 25
48 Clonazepam Rivotril
48A Clonidine Catapres 100
Catapres
49 Clopidogrel Iscover
Plavix
50 Clopidogrel with aspirin CoPlavix
DuoCover
51 Clozapine Clozaril 25
Clozaril 100
52 Codeine with Paracetamol Panadeine Forte
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 9
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
53 Colchicine Colgout
55 Cyproterone Androcur
Androcur-100
56 Desferrioxamine Desferal 500 mg
57 Desvenlafaxine Pristiq
58 Dexamethasone Maxidex Application to the Eye
Ozurdex Implantation
59 Dexamethasone with Framycetin
and Gramicidin
Sofradex
60 Diazepam Valium
61 Diclofenac Voltaren 25
Voltaren 50
62 Digoxin Lanoxin–PG
Lanoxin
63 Diltiazem Cardizem
Cardizem CD
64 Diphenoxylate with Atropine Lomotil
65 Dipyridamole with Aspirin Asasantin SR
66 Docetaxel Taxotere
67 Donepezil Aricept
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
10 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
68 Dorzolamide Trusopt
69 Dorzolamide with timolol Cosopt
70 Doxorubicin – Pegylated
Liposomal
Caelyx
71 Duloxetine Cymbalta
71A Dutasteride Avodart
71B Dutasteride with tamsulosin Duodart 500ug/400ug
72 Electrolyte Replacement, Oral Repalyte New Formulation
73 Enalapril Renitec
Renitec 20
74 Enalapril with Hydrochlorothiazide Renitec Plus 20/6
74A Enoxaparin Clexane
Clexane Safety-Lock
74B Entecavir Baraclude
74C Eplerenone Inspra
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 11
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
75 Epoprostenol Flolan
Flolan Kit
76 Eprosartan Teveten
77 Escitalopram Lexapro
78 Esomeprazole Nexium
78A Esomeprazole and clarithromycin
and amoxicillin
Nexium Hp7
78B Estradiol Progynova
78C Etanercept Enbrel
79 Etoposide Vepesid Oral
Etopophos Injection
79A Everolimus Afinitor
Certican
80 Exemestane Aromasin
80A Ezetimibe Ezetrol
80B Ezetimibe and rosuvastatin Rosuzet Composite Pack
80C Ezetimibe with atorvastatin Atozet
80D Ezetimibe with simvastatin Vytorin
81 Famciclovir Famvir
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
12 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
82 Felodipine Plendil ER
82A Fenofibrate Lipidil
83 Fentanyl Abstral Sublingual
Actiq Buccal
Durogesic 12
Durogesic 25
Durogesic 50
Durogesic 75
Durogesic 100
Transdermal
84 Filgrastim Neupogen
85 Flecainide Tambocor
86 Fluconazole Diflucan
87 Fludarabine Fludara
88 Fluoxetine Prozac 20
Prozac Tab
88A Fluticasone propionate Flixotide
Flixotide Accuhaler
Flixotide Junior
Flixotide Junior Accuhaler
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 13
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
88B Fluticasone propionate with
salmeterol
Seretide Accuhaler 100/50
Seretide Accuhaler 250/50
Seretide Accuhaler 500/50
Seretide MDI 50/25
Seretide MDI 125/25
Seretide MDI 250/25
89 Fluvastatin Lescol XL
90 Fluvoxamine Luvox
91 Folinic acid Leucovorin Calcium (Hospira Pty
Limited)
91A Follitropin Alfa Gonal-f Pen
92 Fosinopril Monopril
93 Fosinopril with
Hydrochlorothiazide
Monoplus 10/12.5
Monoplus 20/12.5
94 Furosemide Lasix
Lasix-M
95 Gabapentin Neurontin
96 Galantamine Reminyl
96A Ganciclovir Cymevene
96B Gefitinib Iressa
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
14 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
97 Gentamicin Genoptic
98 Glibenclamide Daonil
99 Gliclazide Diamicron 60mg MR
100 Glimepiride Amaryl
101 Glipizide Minidiab
102 Glucose Baxter Healthcare Pty Ltd
103 Glyceryl Trinitrate Anginine
Stabilised
Buccal/sublingual
Transiderm-Nitro 25
Transiderm-Nitro 50
Nitro-Dur 5
Nitro-Dur 10
Nitro-Dur 15
Transdermal
104 Granisetron Kytril
105 Hydrochlorothiazide with
Amiloride
Moduretic
106 Hydrocortisone
Solu-Cortef Injection
Hycor Application to the eye
106A Hydromorphone Dilaudid
Dilaudid-HP
Injection
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 15
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
Dilaudid
Jurnista
Oral
106B Hydroxycarbamide Hydrea
107 Hydroxychloroquine Plaquenil
107A Hyoscine Buscopan
108 Hypromellose with Carbomer 980 Genteal gel
109 Hypromellose with Dextran Tears Naturale
109A Ibuprofen Brufen
109B Icatibant Firazyr
110 Idarubicin Zavedos
Zavedos Solution
110A Imatinib Glivec
111 Imipramine Tofranil 10
Tofranil 25
112 Imiquimod Aldara
Aldara Pump
113 Indapamide Natrilix
Natrilix SR
114 Indometacin Indocid
114A Infliximab Remicade
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
16 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
114B Insulin glargine Lantus
Lantus SoloStar
Toujeo SoloStar
115 Interferon Beta-1b Betaferon
116 Ipratropium Atrovent
Atrovent Adult
117 Irbesartan Avapro
Karvea
118 Irbesartan with
Hydrochlorothiazide
Avapro HCT
150/12.5
Avapro HCT
300/12.5
Avapro HCT
300/25
Karvezide
150/12.5
Karvezide
300/12.5
Karvezide
300/25
119 Isosorbide Dinitrate Isordil Sublingual
120 Isosorbide Mononitrate Imdur Durule
Imdur 120 mg
121 Isotretinoin Roaccutane
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 17
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
121A Itraconazole Sporanox
Lozanoc
121B Ivabradine Coralan
122 Ketoprofen Orudis SR 200
123 Labetalol Trandate
124 Lamivudine Zeffix
3TC
125 Lamivudine with Zidovudine Combivir
126 Lamotrigine Lamictal
127 Lansoprazole Zoton FasTabs
128 Latanoprost Xalatan
129 Latanoprost with timolol Xalacom
130 Leflunomide Arava
131 Lercanidipine Zanidip
132 Letrozole Femara 2.5 mg
133 Levetiracetam Keppra
134 Levodopa with Carbidopa Sinemet
Sinemet 100/25
Oral
Duodopa Intra-intestinal
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
18 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
134A Levodopa with carbidopa and
entacapone
Stalevo 50/12.5/200mg
Stalevo 75/18.75/200mg
Stalevo 100/25/200mg
Stalevo 125/31.25/200mg
Stalevo 150/37.5/200mg
Stalevo 200/50/200mg
135 Levonorgestrel with
ethinyestradiol
Microgynon 50 ED Oral Pack containing 21 tablets
125 micrograms-50
micrograms and 7 inert
tablets
Microgynon 30 ED
Nordette 28
Oral Pack containing 21 tablets
150 micrograms-30
micrograms and 7 inert
tablets
Triphasil 28
Triquilar ED
Oral Pack containing 6 tablets
50 micrograms-30
micrograms, 5 tablets
75 micrograms-40
micrograms, 10 tablets
125 micrograms-30
micrograms and 7 inert
tablets
135A Levothyroxine Oroxine
135B Lincomycin Lincocin
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 19
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
136 Lisinopril Zestril
Prinivil 10
Prinivil 20
137 Loperamide Imodium
138 Losartan Cozavan
138A Lurasidone Latuda
139 Macrogol 3350 Movicol Liquid
Movicol
140 Medroxyprogesterone Provera
Depo-Provera
141 Meloxicam Mobic
142 Memantine Ebixa
142A Mercaptopurine Purinethol
143 Metformin Diabex
Diabex 850
Diabex 1000
Diabex XR 500
Diabex XR 1000
144 Methadone Physeptone
145 Methyldopa Aldomet
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
20 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
146 Methylphenidate Ritalin 10
Ritalin LA
147 Methylprednisolone Depo-Medrol
Solu-Medrol
148 Metoclopramide Maxolon
149 Metoprolol Betaloc
Lopresor 50
Lopresor 100
150 Metoprolol succinate Toprol-XL 23.75
Toprol-XL 47.5
Toprol-XL 95
Toprol-XL 190
151 Metronidazole Flagyl
152 Minocycline Minomycin-50
153 Moclobemide Aurorix
Aurorix 300 mg
153A Modafinil Modavigil
154 Mometasone Elocon
Elocon Alcohol Free
155 Montelukast Singulair
156 Morphine DBL Morphine Sulfate
Pentahydrate
Injection
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 21
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
MS Contin
MS Contin Suspension 100 mg
MS Contin Suspension 20 mg
MS Contin Suspension 200 mg
MS Contin Suspension 30 mg
MS Contin Suspension 60 mg
156A Moxonidine Physiotens
157 Mycophenolic Acid Myfortic
CellCept
157A Naloxone Naloxone Hydrochloride (DBL) Injection
Nyxoid Nasal
158 Naltrexone ReVia
159 Naproxen Naprosyn
Naprosyn SR750
Naprosyn SR1000
159A Nebivolol Nebilet
160 Nevirapine Viramune
Viramune XR
161 Nicorandil Ikorel
162 Nifedipine Adalat 10
Adalat 20
Adalat Oros 20mg
Adalat Oros 30
Adalat Oros 60
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
22 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
163 Nitrazepam Mogadon
163A Nitrofurantoin Macrodantin
164 Nizatidine Tazac
165 Norethisterone Micronor
Noriday 28 day
Primolut N
166 Norethisterone with
ethinylestradiol
Brevinor
Brevinor-1
166A Nortriptyline Allegron
167 Octreotide Sandostatin 0.05
Sandostatin 0.1
Sandostatin 0.5
Sandostatin LAR
169 Olanzapine Zyprexa
Zyprexa Zydis
Zyprexa Relprevv
170 Olmesartan Olmetec
170A Olmesartan with amlodipine Sevikar 20/5
Sevikar 40/5
Sevikar 40/10
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 23
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
170B Olmesartan with amlodipine and
hydrochlorothiazide
Sevikar HCT 20/5/12.5
Sevikar HCT 40/10/12.5
Sevikar HCT 40/10/25
Sevikar HCT 40/5/12.5
Sevikar HCT 40/5/25
170C Olmesartan with
hydrochlorothiazide
Olmetec Plus
171 Omalizumab Xolair
172 Omeprazole Losec Tablets
173 Ondansetron Zofran
Zofran Zydis
174 Oxaliplatin Eloxatin
175 Oxazepam Serepax
176 Oxybutynin Ditropan
177 Oxycodone Endone
OxyNorm
OxyContin
Oral
Proladone Rectal
178 Pamidronic Acid Aredia 30 mg
Aredia 90 mg
179 Pantoprazole Somac
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
24 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
180 Paracetamol Panadol Osteo
181 Paroxetine Aropax
181A Pegfilgrastim Neulasta
181B Pemetrexed Alimta
182 Perindopril Coversyl 2.5mg
Coversyl 5mg
Coversyl 10mg
183 Perindopril with amlodipine Coveram 5/5
Coveram 5/10
Coveram 10/5
Coveram 10/10
184 Perindopril with indapamide Coversyl Plus LD 2.5mg/0.625mg
Coversyl Plus 5mg/1.25mg
185 Pindolol Visken 15
186 Pioglitazone Actos
187 Piroxicam Feldene
Feldene-D
188 Polyvinyl Alcohol Liquifilm Tears
189 Pramipexole Sifrol
Sifrol ER
190 Pravastatin Pravachol
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 25
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
191 Prazosin Minipress
191A Pregabalin Lyrica
192 Prochlorperazine Stemetil
193 Propranolol Inderal
194 Quetiapine Seroquel
Seroquel XR
195 Quinapril Accupril
196 Rabeprazole Pariet
197 Raloxifene Evista
198 Ramipril Tritace
Tritace 1.25 mg
Tritace 2.5 mg
Tritace 5 mg
Tritace 10 mg
Tritace Titration Pack
199 Ranitidine Zantac
199A Rasagiline Azilect
200 Riluzole Rilutek
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
26 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
201 Risedronic Acid Actonel
Actonel EC
Actonel Once-a-Month
202 Risedronic Acid and Calcium Actonel EC Combi
203 Risedronic acid and calcium with
colecalciferol
Actonel EC Combi D
204 Risperidone Risperdal
Risperdal Quicklet
Risperdal Consta
204A Rituximab Mabthera
Mabthera SC
204B Rivastigmine
Exelon Oral
Exelon Patch 5
Exelon Patch 10
Exelon Patch 15
Transdermal
204C Rizatriptan Maxalt
205 Rosuvastatin Crestor
206 Roxithromycin Rulide
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 27
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
207 Salbutamol Ventolin Rotacaps
Ventolin CFC-free
Ventolin CFC-Free with dose
counter
Ventolin Nebules
208 Selegiline Eldepryl
209 Sertraline Zoloft
209A Sevelamer Renagel
210 Sildenafil Revatio
211 Simvastatin Lipex 10
Lipex 20
Lipex 40
Lipex 80
Zocor
211A Somatropin Genotropin
Genotropin GoQuick
Genotropin MiniQuick
212 Sorbitol with sodium citrate
dihydrate and sodium lauryl
sulfoacetate
Microlax
213 Sotalol Sotacor
214 Spironolactone Aldactone
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
28 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
215 Sucralfate Carafate
216 Sulfasalazine Salazopyrin
Salazopyrin-EN
217 Sumatriptan Imigran
Imigran FDT
218 Tacrolimus Prograf
Prograf XL
218A Tadalafil Adcirca
219 Tamoxifen Nolvadex-D
220 Telmisartan Micardis
221 Telmisartan with amlodipine Twynsta
222 Telmisartan with
Hydrochlorothiazide
Micardis Plus 40/12.5 mg
Micardis Plus 80/12.5 mg
Micardis Plus 80/25 mg
223 Temazepam Normison
224 Temozolomide Temodal
224A Tenofovir Viread
224B Tenofovir with emtricitabine Truvada
224C Tenofovir with emtricitabine and
efavirenz
Atripla
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 29
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
225 Terbinafine Lamisil (Novartis Pharmaceuticals
Australia Pty Limited)
225A Teriflunomide Aubagio
227 Timolol Timoptol
Timoptol XE
228 Tinidazole Fasigyn
228A Tiotropium Spiriva
Spiriva Respimat
229 Tirofiban Aggrastat
229A Tobramycin DBL Tobramycin
Pfizer Australia Pty Ltd
Injection
Tobi Inhalation
TOBI podhaler Inhalation by mouth
Tobrex Application to the eye
229B Tocilizumab Actemra
Actemra ACTPen
Actemra Subcutaneous Injection
230 Topiramate Topamax
Topamax Sprinkle
231 Topotecan Hycamtin
Authorised Version F2020C00906 registered 08/10/2020
Schedule 1 Originator Brand
30 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
232 Tramadol
Tramal
Tramal SR 50
Tramal SR 100
Tramal SR 150
Tramal SR 200
Tramal 100
233 Trandolapril Gopten
233A Tranexamic Acid Cyklokapron
233B Trastuzumab Herceptin
Herceptin SC
234 Triamcinolone Kenacort-A10 Injection
Aristocort 0.02% Application
235 Triamcinolone with Neomycin,
Gramicidin and Nystatin
Kenacomb Otic
236 Trimethoprim Triprim
237 Trimethoprim with
Sulfamethoxazole
Bactrim
Bactrim DS
238 Ursodeoxycholic Acid Ursofalk
239 Valaciclovir Valtrex
239A Valganciclovir Valcyte
240 Valproic Acid Epilim EC
Authorised Version F2020C00906 registered 08/10/2020
Originator Brand Schedule 1
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 31
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Column 1 Column 2 Column 3 Column 4 Column 5
Item Drug Originator Brand Manner of
administration Form
241 Valsartan Diovan
242 Valsartan with
hydrochlorothiazide
Co-Diovan 80/12.5
Co-Diovan 160/12.5
Co-Diovan 160/25
Co-Diovan 320/12.5
Co-Diovan 320/25
243 Vancomycin
Vancocin
Vancocin CP
244 Venlafaxine Efexor-XR
245 Verapamil Isoptin
Isoptin SR
Isoptin 180 SR
246 Vinorelbine Navelbine
246A Voriconazole Vfend
247 Ziprasidone Zeldox
247A Zoledronic acid Aclasta
Zometa
248 Zolmitriptan Zomig
248A Zonisamide Zonegran
Authorised Version F2020C00906 registered 08/10/2020
Endnotes
Endnote 1—About the endnotes
32 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Endnotes
Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or
will amend) the compiled law. The information includes commencement details for amending
laws and details of any application, saving or transitional provisions that are not included in
this compilation.
The amendment history in endnote 4 provides information about amendments at the provision
(generally section or equivalent) level. It also includes information about any provision of the
compiled law that has been repealed in accordance with a provision of the law.
Editorial changes
The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and
presentational changes to a compiled law in preparing a compilation of the law for
registration. The changes must not change the effect of the law. Editorial changes take effect
from the compilation registration date.
If the compilation includes editorial changes, the endnotes include a brief outline of the
changes in general terms. Full details of any changes can be obtained from the Office of
Parliamentary Counsel.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe the
amendment to be made. If, despite the misdescription, the amendment can be given effect as
intended, the amendment is incorporated into the compiled law and the abbreviation “(md)”
added to the details of the amendment included in the amendment history.
If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not
incorp)” is added to the details of the amendment included in the amendment history.
Authorised Version F2020C00906 registered 08/10/2020
Endnotes
Endnote 2—Abbreviation key
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 33
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Endnote 2—Abbreviation key
ad = added or inserted o = order(s)
am = amended Ord = Ordinance
amdt = amendment orig = original
c = clause(s) par = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x /sub-subparagraph(s)
Ch = Chapter(s) pres = present
def = definition(s) prev = previous
Dict = Dictionary (prev…) = previously
disallowed = disallowed by Parliament Pt = Part(s)
Div = Division(s) r = regulation(s)/rule(s)
ed = editorial change reloc = relocated
exp = expires/expired or ceases/ceased to have renum = renumbered
effect rep = repealed
F = Federal Register of Legislation rs = repealed and substituted
gaz = gazette s = section(s)/subsection(s)
LA = Legislation Act 2003 Sch = Schedule(s)
LIA = Legislative Instruments Act 2003 Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given SLI = Select Legislative Instrument
effect SR = Statutory Rules
(md not incorp) = misdescribed amendment Sub-Ch = Sub-Chapter(s)
cannot be given effect SubPt = Subpart(s)
mod = modified/modification underlining = whole or part not
No. = Number(s) commenced or to be commenced
Authorised Version F2020C00906 registered 08/10/2020
Endnotes
Endnote 3—Legislation history
34 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Endnote 3—Legislation history
Name Registration Commencement Application, saving
and transitional
provisions
PB 100 of 2015 29 Sept 2015
(F2015L01525)
1 Oct 2015 (s 2)
PB 114 of 2015 1 Dec 2015
(F2015L01905)
1 Dec 2015 (s 2) —
PB 127 of 2015 24 Dec 2015
(F2015L02140)
1 Jan 2015 (s 2) —
PB 8 of 2016 1 Feb 2016
(F2016L00083)
1 Feb 2016 (s 2) —
PB 27 of 2016 1 Apr 2016
(F2016L00471)
1 Apr 2016 (s 2) —
PB 38 of 2016 29 Apr 2016
(F2016L00606)
1 May 2016 (s 2) —
PB 49 of 2016 31 May 2016
(F2016L00869)
1 June 2016 (s 2) —
PB 71 of 2016 28 July 2016
(F2016L01245)
1 Aug 2016 (s 2) —
PB 79 of 2016 25 Aug 2016
(F2016L01329)
1 Sept 2016 (s 2) —
PB 89 of 2016 28 Sept 2016
(F2016L01537)
1 Oct 2016 (s 2) —
PB 105 of 2016 30 Nov 2016
(F2016L01840)
1 Dec 2016 (s 2) —
PB 11 of 2017 27 Jan 2017
(F2017L00078)
1 Feb 2017 (s 2) —
PB 23 of 2017 30 Mar 2017
(F2017L00360)
1 Apr 2017 (s 2) —
PB 33 of 2017 28 Apr 2017
(F2017L00487)
1 May 2017 (s 2) —
PB 42 of 2017 31 May 2017
(F2017L00632)
1 June 2017 (s 2) —
PB 50 of 2017 29 June 2017
(F2017L00823)
1 July 2017 (s 2) —
PB 61 of 2017 27 July 2017
(F2017L00962)
1 Aug 2017 (s 2) —
PB 80 of 2017 29 Sept 2017
(F2017L01307)
1 Oct 2017 (s 2) —
PB 98 of 2017 29 Nov 2017
(F2017L01550)
1 Dec 2017 (s 2) —
PB 11 of 2018 30 Jan 2018
(F2018L00061)
1 Feb 2018 (s 2) —
Authorised Version F2020C00906 registered 08/10/2020
Endnotes
Endnote 3—Legislation history
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) 35
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Name Registration Commencement Application, saving
and transitional
provisions
PB 26 of 2018 28 Mar 2018
(F2018L00419)
1 Apr 2018 (s 2) —
PB 44 of 2018 31 May 2018
(F2018L00696)
1 June 2018 (s 2) —
PB 60 of 2018 29 June 2018
(F2018L00957)
1 July 2018 (s 2) —
PB 71 of 2018 1 Aug 2018
(F2018L01073)
1 Aug 2018 (s 2) —
PB 88 of 2018 27 Sept 2018
(F2018L01351)
1 Oct 2018 (s 2) —
PB 105 of 2018 29 Nov 2018
(F2018L01635)
1 Dec 2018 (s 2) —
PB 6 of 2019 31 Jan 2019
(F2019L00079)
1 Feb 2019 (s 2) —
PB 25 of 2019 29 Mar 2019
(F2019L00467)
1 Apr 2019 (s 2) —
PB 34 of 2019 30 Apr 2019
(F2019L00657)
1 May 2019 (s 2) —
PB 42 of 2019 31 May 2019
(F2019L00715)
1 June 2019 (s 2) —
PB 64 of 2019 30 July 2019
(F2019L01017)
1 Aug 2019 (s 2) —
PB 73 of 2019 30 Aug 2019
(F2019L01121)
1 Sept 2019 (s 2) —
PB 82 of 2019 30 Sept 2019
(F2019L01292)
1 Oct 2019 (s 2) —
PB 90 of 2019 31 Oct 2019
(F2019L01396)
1 Nov 2019 (s 2) —
PB 99 of 2019 27 Nov 2019
(F2019L01512)
1 Dec 2019 (s 2) —
PB 9 of 2020 31 Jan 2020
(F2020L00077)
1 Feb 2020 (s 2) —
PB 27 of 2020 31 Mar 2020
(F2020L00362)
1 Apr 2020 (s 2) —
PB 49 of 2020 29 May 2020
(F2020L00640)
1 June 2020 (s 2) —
PB 74 of 2020 31 July 2020
(F2020L00970)
1 Aug 2020 (s 2) —
PB 85 of 2020 28 Aug 2020
(F2020L01086)
1 Sept 2020 (s 2(1) item 1) —
PB 96 of 2020 30 Sept 2020
(F2020L01257)
1 Oct 2020 (s 2(1) item 1) —
Authorised Version F2020C00906 registered 08/10/2020
Endnotes
Endnote 4—Amendment history
36 National Health (Originator Brand) Determination 2015 (PB 100 of 2015)
Compilation No. 40 Compilation date: 01/10/2020 Registered: 08/10/2020
Endnote 4—Amendment history
Provision affected How affected
s 2 .................................................. rep LIA s 48D
Schedule 1
Schedule 1 ..................................... am PB 114 and 127 of 2015; PB 8, 27, 38, 49, 71, 79, 89 and 105 of 2016; PB 11 of 2017;
PB 23 of 2017; PB 33 of 2017; PB 42 of 2017; PB 50 of 2017; PB 61 of 2017; PB 80 of
2017; PB 98 of 2017; PB 11 of 2018; PB 26 of 2018
ed C20
am PB 44 of 2018
ed C21
am PB 60 of 2018; PB 71 of 2018; PB 88 of 2018; PB 105 of 2018; PB 6 of 2019; PB 25 of
2019; PB 34 of 2019; PB 42 of 2019; PB 64 of 2019; PB 73 of 2019; PB 82 of 2019; PB 90
of 2019; PB 99 of 2019; PB 9 of 2020; PB 27 of 2020; PB 49 of 2020; PB 74 of 2020; PB 85
of 2020; PB 96 of 2020
Authorised Version F2020C00906 registered 08/10/2020